Edition:
United States

Ritter Pharmaceuticals Inc (RTTR.OQ)

RTTR.OQ on NASDAQ Stock Exchange Capital Market

0.30USD
8 Dec 2017
Change (% chg)

$-0.01 (-2.55%)
Prev Close
$0.31
Open
$0.32
Day's High
$0.32
Day's Low
$0.30
Volume
32,879
Avg. Vol
196,265
52-wk High
$3.75
52-wk Low
$0.28

Select another date:

Tue, Oct 3 2017

BRIEF-‍sabby Management reports 9.94 pct passive stakee in Ritter Pharmaceuticals

* ‍sabby Management, LLC​ reports 9.94 percent passive stakee in Ritter Pharmaceuticals Inc as of September 29 - sec filing Source text : http://bit.ly/2yWkm3T Further company coverage:

BRIEF-RITTER PHARMA RAISES $23 MLN TO FUND PHASE 3 CLINICAL PROGRAM IN LACTOSE INTOLERANCE

* RITTER PHARMACEUTICALS, INC. RAISES $23 MILLION TO FUND INITIATION OF ITS PHASE 3 CLINICAL PROGRAM IN LACTOSE INTOLERANCE

BRIEF-Ritter Pharmaceuticals Inc prices $23,000,000 public offering

* Ritter Pharmaceuticals, Inc. prices $23,000,000 public offering

BRIEF-Ritter Pharma announces Phase 3 plans after end of Phase 2 meeting with FDA on RP-G28

* Ritter Pharmaceuticals announces Phase 3 plans after its end of Phase 2 meeting with FDA on RP-G28 for lactose intolerance

BRIEF-Ritter Pharmaceuticals reports further analysis from its phase 2b/3 trial results demonstrating significant reductions in lactose intolerance symptoms

* Ritter Pharmaceuticals reports further analysis from its phase 2b/3 trial results demonstrating significant reductions in lactose intolerance symptoms

BRIEF-Ritter pharmaceuticals files for offering of up to $10 mln ‍​

* Ritter Pharmaceuticals files for offering of up to $10 million of class a units consisting of stock and warrants and class b units consisting of preferred stock & warrants ‍​ Source text (http://bit.ly/2skn9QC) Further company coverage:

Select another date: